ArticleBioinformation2026
Red cell distribution width and platelet indices as predictors of mortality in acute coronary syndrome: A prospective observational study.
Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute Coronary Syndrome (ACS) is a leading cause of cardiovascular mortality and simple hematological markers may help predict outcomes. Baseline laboratory parameters were recorded and patients were followed for in-hospital mortality and ICU requirement in this prospective study of 140 ACS patients admitted during 2024,. The mean age was 59.3 ± 10.7 years, with 65.7% males, and adverse outcomes occurred in 8.6%. Non-survivors had significantly higher RDW, mean platelet volume (MPV) and platelet distribution width (PDW). RDW-SD showed the highest predictive accuracy, followed by NLR and RDW-CV. Multivariate analysis identified creatinine, RDW, PDW, NLR, MPV, and urea as independent mortality predictors, while higher hemoglobin was protective, supporting the role of routine, low-cost markers in early ACS risk stratification.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.